Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Aug 2026 for Lexeo Therapeutics, Inc., €14k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Townsend Richard Nolan: trading record in brief
All filings by Townsend Richard Nolan on record concern Lexeo Therapeutics, Inc. The record holds 2 filings, for trades running from 1 July 2026 to 18 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 18 August 2026 came the latest disclosure, a transaction for €14k in Lexeo Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Townsend Richard Nolan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
3,345 shares@ US$4.9512CommonSEC144:0001959173-26-006154
25,947 shares@ US$4.47780.032% mcap18.1% of flowCommonSEC144:0001959173-26-005031
2 of 2 declarations
